Covid: treatments - Revision history

Rasmusen p1vaim at 05:55, 24 November 2021

2021-11-24T05:55:01Z

Rasmusen p1vaim: /* General */

2021-11-24T05:54:03Z

‎General

Rasmusen p1vaim at 18:46, 23 November 2021

2021-11-23T18:46:05Z

Rasmusen p1vaim at 13:44, 6 June 2021

2021-06-06T13:44:16Z

Rasmusen p1vaim: Created page with "[https://sebastianrushworth.com/2021/05/09/update-on-ivermectin-for-covid-19/ "Update on ivermectin for covid-19,"] Sebuastin Rushworth (April 2021).

2021-05-09T19:29:13Z

Created page with "[https://sebastianrushworth.com/2021/05/09/update-on-ivermectin-for-covid-19/ "Update on ivermectin for covid-19,"] Sebuastin Rushworth (April 2021). <blockquote style="color..."

New page
[https://sebastianrushworth.com/2021/05/09/update-on-ivermectin-for-covid-19/ "Update on ivermectin for covid-19,"] Sebuastin Rushworth (April 2021).
<blockquote style="color:gray">
There is one thing that is rather odd with this study, and that is that the study authors were receiving payments from Sanofi-Pasteur, Glaxo-Smith-Kline, Janssen, Merck, and Gilead while conducting the study. Gilead makes remdesivir. Merck is developing two expensive new drugs to treat covid-19. Janssen, Glaxo-Smith-Kline, and Sanofi-Pasteur are all developers of covid vaccines. In other words, the authors of the study were receiving funding from companies that own drugs that are direct competitors to ivermectin. One might call this a conflict of interest, and wonder whether the goal of the study was to show a lack of benefit. It’s definitely a little bit suspicious...

Tthis study is yet another one of those many studies that will not be able to show a meaningful effect on hard end points like hospitalization and death. It is a bit strange that studies keep being done on young healthy people who are at virtually zero risk from covid-19, rather than on the multi-morbid elderly, who are the ones we actually need an effective treatment for.
</blockquote>
<html><img src="http://rasmusen.org/EricRasmusen2007.jpg" height= 20 align=left></html>
<blockquote style="color:gray">
</blockquote>

← Older revision		Revision as of 05:55, 24 November 2021
Line 1:		Line 1:
−		+	See also [[Ivermectin]].


Line 18:		Line 18:

	----		----
−	~~==Ivermectin==~~
−	*[https://sebastianrushworth.com/2021/05/09/update-on-ivermectin-for-covid-19/ "Update on ivermectin for covid-19,"] Sebastian Rushworth (April 2021).
−	~~<blockquote style="color:gray">~~
−	There is one thing that is rather odd with this study, and that is that the study authors were receiving payments from Sanofi-Pasteur, Glaxo-Smith-Kline, Janssen, Merck, and Gilead while conducting the study. Gilead makes remdesivir. Merck is developing two expensive new drugs to treat covid-19. Janssen, Glaxo-Smith-Kline, and Sanofi-Pasteur are all developers of covid vaccines. In other words, the authors of the study were receiving funding from companies that own drugs that are direct competitors to ivermectin. One might call this a conflict of interest, and wonder whether the goal of the study was to show a lack of benefit. It’s definitely a little bit suspicious...
−
−	Tthis study is yet another one of those many studies that will not be able to show a meaningful effect on hard end points like hospitalization and death. It is a bit strange that studies keep being done on young healthy people who are at virtually zero risk from covid-19, rather than on the multi-morbid elderly, who are the ones we actually need an effective treatment for.
−	~~</blockquote>~~
−	~~<html><img src="http://rasmusen.org/EricRasmusen2007.jpg" height= 20 align=left></html>~~
−	~~<blockquote style="color:gray">~~
−	~~</blockquote>~~

@@ Line 1: / Line 1: @@
 ==General==
 *[https://aapsonline.org/CovidPatientTreatmentGuide.pdf "A Guide to Home-Based Covid Treatment,"] from a reputable source, a pdf book.
 ----

@@ Line 1: / Line 1: @@
 *[https://aapsonline.org/CovidPatientTreatmentGuide.pdf "A Guide to Home-Based Covid Treatment,"] from a reputable source, a pdf book.
-[https://sebastianrushworth.com/2021/05/09/update-on-ivermectin-for-covid-19/ "Update on ivermectin for covid-19,"] Sebastian Rushworth (April 2021).
+----
 <blockquote style="color:gray">
 There is one thing that is rather odd with this study, and that is that the study authors were receiving payments from Sanofi-Pasteur, Glaxo-Smith-Kline, Janssen, Merck, and Gilead while conducting the study. Gilead makes remdesivir. Merck is developing two expensive new drugs to treat covid-19. Janssen, Glaxo-Smith-Kline, and Sanofi-Pasteur are all developers of covid vaccines. In other words, the authors of the study were receiving funding from companies that own drugs that are direct competitors to ivermectin. One might call this a conflict of interest, and wonder whether the goal of the study was to show a lack of benefit. It’s definitely a little bit suspicious...